Risperidone (Risperdal) Augmentation in Depressed Partial Responders to SRI Treatment

NCT00178854 · clinicaltrials.gov ↗

PHASE4

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped failed recruitment efforts

Conditions

Treatment Resistant Depression

Interventions

DRUG: Risperidone

Sponsor

Vanderbilt University Medical Center

Collaborators

[object Object]